Best Human Biosciences Podcasts (2024)

1
Triple Helix Podcast on burns 13:19

2d ago13:19

13:19

In this episode, Dan and Amara discuss some personal memories of burns caused while cooking, how Dan used a Celluheal™ product on his burns, and then Dan brings you a practical guide on how to deal with everyday burns.By Human Biosciences

1
Episode 62: Josh Mandel-Brehm - CEO, CAMP4 Therapeutics 20:10

2M ago20:10

20:10

Explore the untapped potential of RNA amplifying therapeutics with the CEO of CAMP4 Therapeutics, Josh Mandel-Brehm. We uncover the power of antisense oligonucleotides in rewriting the narrative for genetic diseases characterized by protein deficiency. Josh takes us behind the scenes of their innovative RNA Actuating Platform (RAP), a map charting …

1
Harnessing the Secretome to Combat Age-Related Immune Dysfunction (Dr. Hans Keirstead, Immunis) 47:38

2M ago47:38

47:38

Hans Keirstead, PhD, is the Chairman of the Board at Immunis, a biotechnology company researching and developing immune secretome products to address age-driven immune deficits. In this episode, Chris and Hans discuss Immunis' approach to targeting the aging immune system as a key driver of age-related disease. They explore the potential of immune …

1
Episode 61: William Korinek - CEO and Co-Founder, Astrocyte Pharmaceuticals 24:20

2M ago24:20

24:20

Embark on a journey through the neurons and synapses of brain science with William Korinek, the CEO of Astrocyte Pharmaceuticals. In a conversation that fuses the molecular intricacies of neuroprotection with the humanistic pursuit of medical advancement, Bill reveals his unique path from molecular biologist to biotech innovator. Together, we unrav…

1
Episode 60: Rachel Haines - VP of Clinical Development & Operations, Rinri Therapeutics 18:30

2M ago18:30

18:30

By Vial

1
Episode 59: Bas van der Baan - President & CEO, Lixte Biotechnology 17:32

2M ago17:32

17:32

Join as we dive deep into the world of oncology drug development with Bas van der Baan of Lixte. Discover the inspiration behind Lixte's focus on PP2A inhibitors and how this innovative approach is poised to revolutionize cancer treatment by enhancing chemotherapy and immunotherapy responses. Bas shares insights into ongoing clinical trials, regula…

1
Delaying menopause, extending healthspan: The promise of AMH-based therapeutics (Daisy Robinton, Oviva Therapeutics) 36:35

3M ago36:35

36:35

Dr. Daisy Robinton, co-founder and CEO of Oviva Therapeutics, discusses the company's innovative approach to improving women's healthspan by targeting the biology of ovarian aging. Motivated by her personal experiences and the realization that female physiology is underserved by research and medicine, Daisy outlines how menopause is a key inflectio…

1
Episode 58: Samarendra Mohanty - President & CSO, Nanoscope Therapeutics 16:36

3M ago16:36

16:36

Dr. Samar Mohanty, president and CSO of Nanoscope Therapeutics joins us to shed light on the revolutionary gene therapy that's giving hope to individuals with retinal degenerative diseases by pioneering a treatment that can re-sensitize the retina to detect low light levels. We open the curtains on their groundbreaking multi-characteristic opsins (…

1
Gene Therapies to Treat and Reverse Aging (Noah Davidsohn, Rejuvenate Bio) 35:14

3M ago35:14

35:14

Dr. Noah Davidsohn, co-founder and CSO of Rejuvenate Bio, discusses the company's innovative work using gene therapies to treat age-related diseases in dogs and humans. In his conversation with host Chris Patil, he explains his recent groundbreaking study showing that partial cellular reprogramming with Yamanaka factors extended lifespan and health…

1
Episode 57: Rob Etherington- CEO and President at Clene Nanomedicine 20:06

4M ago20:06

20:06

Imagine unlocking the secrets to revitalizing the brain's energy centers and turning the tide on neurodegenerative diseases. In this episode, Rob introduces us to CNM-Au8, an oral nanotherapeutic with the potential to recharge failing mitochondria. Our discussion traverses the innovative path Clene has charted, from the drug's conception to the exc…

1
Episode 56: Jason Bock- Founder and CEO at CTMC 22:28

4M ago22:28

22:28

Step into the future as Dr. Jason Bock, founder and CEO of CTMC discusses the company's unique approach to accelerating cell therapies from development to testing, and the power of collaboration in reshaping the future of cancer treatment. Listen in as we discuss how CTMC's partnership with MD Anderson is not just technical but deeply human in natu…

1
Episode 55: Alex Federation- Co-Founder at Talus Bio 15:27

4M ago15:27

15:27

Embark on a quest to unravel the 'undruggable' genome with Alex Federation, Co-founder of Talus Bio. Explore challenges in targeting transcription factors in cancer with Talus's innovative Marmot platform. Discover potential breakthroughs in rare diseases and pediatric cancers, and glimpse into the future of studying transcription factors within li…

1
Episode 54: Ahmed Hamdy- CEO at Vincerx Pharma 16:52

4M ago16:52

16:52

Join Dr. Ahmed Hamdy, CEO of Vincerx Pharma, on a compelling journey through oncology. From co-founding Acerta Pharma to pioneering patient-centric innovations, Dr. Hamdy shares his impactful career. Explore the groundbreaking VersAptx bioconjugation platform, designed to elevate cancer therapies and uncover the delicate balance between clinical ex…

1
Episode 53: Sam Clark- CEO & Founder at Terran Biosciences 18:10

5M ago18:10

18:10

Have you ever considered the untapped potential of abandoned drugs? Join Dr. Sam Clark to discuss how his personal drive to combat mental illness is leading to breakthroughs in treatments for neurological and psychiatric diseases. Witness how Terran is not only resurrecting discarded medications for new purposes, but also pioneering the next genera…

1
Episode 52: Mark McDonough- President & CEO of ChromaCode 16:54

5M ago16:54

16:54

Ever wondered how technology could drastically improve early detection in healthcare? Let us take you on a journey with Mark McDonough, President and CEO of ChromaCode, as we unfold the world of molecular diagnostics with a special focus on HDPCR technology. Mark, with his diverse background in the military and healthcare, brings a fresh perspectiv…

1
Episode 51: Bogdan Knezevic - Co-founder & CEO at Kaleidoscope.bio 21:16

5M ago21:16

21:16

Embark on a journey through the intricate world of biotech with Bogdan Kezevic, co-founder and CEO of Kaleidoscope Bio, and uncover the revolutionary software shaping the future of scientific research. Bogdan's leap from scientist to entrepreneur has led to groundbreaking solutions for the challenges plaguing biotech. In our chat, he shares how dat…

1
Episode 50: Steven Reed - Co-Founder & CEO at HDT Bio 12:19

5M ago12:19

12:19

What does it take to revolutionize the world of vaccines and touch lives across the globe? Join us on a riveting journey with Steven Reed, CEO and co-founder of HDT-Bio, as we explore the creation of the first refined tuberculosis vaccine and dive into the remarkable strides in RNA technology. This episode lifts the veil on the science that could r…

1
Episode 49: Jeffrey Bacha - Chairman, Rakovina Therapeutics 21:45

6M ago21:45

21:45

Join Jeffrey Bacha, a pioneer in the fight against cancer and the creative force behind Rakovina Therapeutics. For 25 years, Jeffrey has been reshaping the industry landscape, and today, he gives us a peek into his world of innovation. We venture into Rakovina's research and development of oncology drugs. exploring their groundbreaking technique co…

1
Episode 48: Jonathan Thon - Founder & CEO at STRM.BIO 21:52

7M ago21:52

21:52

Embark on a fascinating exploration of biotech entrepreneurship, guided by an expert who's been in the trenches: Jonathan Thon, CEO and founder of STRM.BIO. We'll give you an insider's view of his journey from academia to the cutting edge of biotech, unveiling his trailblazing work on platelet production and the transformative potential of extracel…

1
30 Years of Aging Biology: A Pioneer's Perspective (Cynthia Kenyon, VP-Aging Research at Calico Labs) 44:06

7M ago44:06

44:06

30 Years of Aging Biology: A Pioneer’s Perspective (Cynthia Kenyon - VP Aging Biology, Calico Labs) Dr. Cynthia Kenyon reflects on the evolution of the longevity field over the 30 years since the publication of her groundbreaking paper, “A C. elegans mutant that lives twice as long as wild type,” a genetic analysis of one of the first single-gene m…

1
Triple Helix Podast Dr Heather Flexer Common Wounds and Celluheal 28:42

7M ago28:42

28:42

In this episode of the Triple Helix Podcast, we're featuring Dr. Heather Flexer once again, discussing how Celluheal™ products can help with everyday, common injuries. We have a little fun with the topic but provide good professional advice for how to use Celluheal™ in our everyday lives, for ourselves, or our friends and families.…

1
Episode 47: Oscar Segurado- CMO at ASC Therapeutics 22:00

7M ago22:00

22:00

Ever wondered how far we've truly come in the realm of gene and cell therapies, and where we're headed next? This captivating conversation with Oscar Segurado, the CMO of ASC Therapeutics, will satisfy your curiosity. Oscar, a veteran in the biopharmaceutical industry, shares fascinating insights on ASC Therapeutics' groundbreaking innovation in pe…

1
XPRIZE Healthspan: Catalyzing Therapies for Aging (Jamie Justice, PhD) 55:16

7M ago55:16

55:16

Dr. Jamie Justice is Executive Director of the newly launched XPRIZE Healthspan, a $101 M international competition to accelerate therapeutics targeting aging biology. In conversation with host Chris Patil, Dr. Justice outlines the motivation, structure, and timeline of the prize, as well as how teams can get involved. She also explains unique aspe…

1
Episodes 46: Spiro Rombotis- CEO at Cyclacel 21:28

7M ago21:28

21:28

We’re thrilled to share our enlightening exchange with Spiro Rombotis, the seasoned CEO of Cyclacel. He peels back the curtain on the breakthrough discovery of B53, a commonly mutated gene in cancer patients, and the inspiring success of FADRA, their lead drug in clinical trials. Furthermore, Spiro delves into the highs and lows faced by Cyclacel, …

1
"How We Age: The Science of Longevity" (Professor Coleen Murphy, Princeton) 36:33

8M ago36:33

36:33

Dr. Coleen Murphy is a prominent aging researcher and author of the upcoming book “How We Age: The Science of Longevity” from Princeton University Press. In this wide-ranging discussion, Coleen provides insights into her motivation for writing this book, key topics covered, and her unique perspective on the field. Key ideas: Addressing ethical conc…

1
Special Halloween CelluHeal Edition 16:49

8M ago16:49

16:49

Heather Flexer is our guest on this special Halloween episode of the Triple Helix podcast. A doctor of physical therapy and a board-certified Wound Specialist CWS, Heather works in the field of wound care, post-surgery care, and wellness, as well as contributing content to our site. A long-time proponent of mind-body/holistic health, Heather brings…

1
Episode 45: Frank Borriello- Founder and CEO at Alloplex Biotherapeutics 17:56

8M ago17:56

17:56

Ever wondered about the people who are leading the fight against cancer, developing groundbreaking treatments, and changing lives? Meet Frank Boriello, the mind behind SUPLEXA cell therapy, and the CEO and founder of Alloplex Biotherapeutics. In our conversation, Frank shares the personal backstory that sparked his quest to revolutionize cancer tre…

1
Episode 44: Max Darnell- CEO & Co-Founder at Modulus Therapeutics 14:18

9M ago14:18

14:18

Max Darnell, CEO and co-founder of Modulus Therapeutics, takes us through his thrilling journey from bioengineering and systems biology to launching a biotech startup. Max unveils how his team's curiosity and motivation, along with their high throughput discovery platform, are revolutionizing cell and cell therapy component designs. Hear how Modulu…

1
From Startup to Acquisition (Nick Hertz, Mitokinin) 41:59

9M ago41:59

41:59

Dr. Nicholas Hertz is the co-founder and former CSO of Mitokinin, a biotech company developing therapies targeting damaged mitochondria in neurodegenerative disease. Mitokinin was recently acquired by pharmaceutical giant AbbVie. In this episode, Nick recounts the journey from academic research on PINK1 biology to founding a startup and advancing a…

1
Episode 43: Pepper Landson- Co-Founder & CEO of Praetego 19:03

9M ago19:03

19:03

Join 30-year industry veteran Pepper Landson, Co-founder and CEO of Praetego as she shares her inspiring journey that led her to tackle Alzheimer's and dementia through the innovative use of amadorins. Pepper's intriguing narrative not only highlights her commitment to the public health crisis surrounding these neurodegenerative diseases, but also …

1
Catalyzing moonshots in longevity biotech (Alex Colville, Age1) 40:34

9M ago40:34

40:34

Dr. Alex Colville is the co-founder and General Partner of Age1 Ventures, a recently launched VC firm focused on funding contrarian, founder-led biotech companies aiming to extend healthy human lifespan. In this episode, Alex outlines Age1's thesis of identifying and empowering talented founders with ambitious visions for the longevity field. He sh…

1
Episode 42: Dr. Timothy Miller - Co-Founder, President, & CEO at Forge Biologics 12:34

9M ago12:34

12:34

Ever wonder how the complexities of gene therapies are addressed from bench to bedside? The creative solutions lie within the innovative approaches of seasoned professionals like Dr. Timothy Miller, Co-Founder, President, & CEO at Forge Biologics. With a fascinating career that interlaces academia, biotech, and entrepreneurship, Dr. Miller brings a…

1
Episode 41: David Esposito - President and CEO at ONL Therapeutics 19:35

9M ago19:35

19:35

What if your vision could be saved by the precise application of innovative biotech? Join us as we talk to David Esposito, President & CEO of ONL Therapeutics, and delve deep into his take on leadership. He shares how his military background has been instrumental in the successful management of clinical trials, particularly when navigating the unpr…

1
Episode 40: Alfredo Andere - Co-Founder & CEO at LatchBio 24:41

10M ago24:41

24:41

Does the convergence of tech and biology hold the key to reshaping biotech's data infrastructure? Our recent chat with Alfredo Andere, Co-Founder and CEO at LatchBio, certainly supports this notion. This episode offers a deep dive into Alfredo's journey from being part of the Google Brain team to co-founding Latch Bio - a company that is making wav…

1
Episode 39: Lucas Siow - CEO & Co-Founder at ProteinQure 15:05

10M ago15:05

15:05

Embark on a journey into the forefront of biotech with Lucas Siow, the visionary behind ProteinQure, as he unveils the impact of his computational platform on peptide therapeutics and delves into the art of team building. Explore the fusion of medicinal chemistry and high throughput screens, discover the essence of benchmarking in drug discovery, a…

1
Reversing Skin Aging at the Cellular Level (Carolina Reis Oliveira and Alessandra Zonari, OneSkin) 35:51

10M ago35:51

35:51

Dr. Carolina Reis Oliveira and Dr. Alessandra Zonari are the co-founders of OneSkin, a company developing science-backed skincare products to reverse skin aging at the cellular level. In this episode, Carolina and Alessandra tell host Dr. Chris Patil how OneSkin is leveraging recent advances in longevity science to create novel peptides that target…

1
Discovering New Senolytics with Neural Networks (Felix Wong, Integrated Biosciences) 37:01

11M ago37:01

37:01

Dr. Felix Wong is a co-founder of Integrated Biosciences, an early-stage biotech company developing next-generation therapeutics for cellular rejuvenation. He is also a postdoc at MIT and the Broad Institute and was a lead author on a recent Nature Aging paper describing the use of graph neural networks to discover new senolytic compounds. In this …

1
“Taking disease by sTORm”: Developing Rapalogs to Extend Healthy Lifespan (Joan Mannick, Tornado Therapeutics) 29:16

11M ago29:16

29:16

Joan Mannick, CEO and co-Founder of Tornado Therapeutics, joins the podcast to discuss her company’s exciting mission of developing a new generation of rapalog compounds specifically targeting the TORC1 complex. Rapalogs are analogs of the natural compound rapamycin, which has been shown to extend lifespan and healthspan in animal models by inhibit…

1
Discovering Healthspan Interventions through Phenotype-Based Drug Screening (Mitchell Lee, Ora Biomedical) 32:16

12M ago32:16

32:16

Mitchell Lee is the CEO and co-founder of Ora Biomedical, a Seattle-based biotech company using large-scale phenotypic drug screening in C. elegans to discover small molecule therapeutics that extend lifespan and healthspan. In this episode, Chris and Mitch discuss Ora's approach to drug discovery, which focuses on function and phenotype rather tha…

Podcasts Worth a Listen

Human Biosciences Podcasts

Podcasts Worth a Listen

Quick Reference Guide